天然草本植物调控铁死亡与线粒体自噬治疗非小细胞肺癌的潜力
本文综述天然草本植物及其活性成分通过调控铁死亡与线粒体自噬途径治疗非小细胞肺癌(NSCLC)的民族药理学应用。研究基于传统医学文献与PubMed、CNKI等数据库,检索关键词包括中药复方、单味药提取物、活性化合物、NSCLC、铁死亡和线粒体自噬。结果表明多种中药复方、单味药提取物及活性成分可作用于多靶点(如GPX4、FSP1、P53、Nrf2等),且肝腎毒性较常规西药低,具有开发为NSCLC治疗药物的潜力。
要点
- 中药复方及活性成分可多靶点调控铁死亡与线粒体自噬相关通路。
- 防己黄芪汤、木防己汤等复方临床疗效可观,但其活性成分需机制研究验证。
- 天然草本植物肝腎毒性相对较低,但需全面评估资源、质控与毒理。
核心结论
- 多种中药复方、单味药提取物及活性成分通过调控铁死亡和线粒体自噬多条信号通路,对NSCLC显示抗肿瘤、抗炎、抗氧化等生物活性,且肝腎毒性较低,是潜在的NSCLC治疗候选药物。
研究设计与样本
- 综述类研究,检索传统医学典籍及PubMed、CNKI等在线数据库中近年文献,关键词为中药复方、单味药提取物、活性化合物、NSCLC、铁死亡和线粒体自噬。
主要发现
- 铁死亡与线粒体自噬涉及PINK1/Parkin、HMGB1、system Xc-/GPX4/GSH、FSP1/CoQ10/NAD(P)H等多条信号通路,单靶点药物难以全面干预。
- 多种草本植物及其活性成分可作用于NIX、BNIP3、FUNDC1、GPX4、FSP1、P53、Nrf2、LncRNA等多个与NSCLC铁死亡和线粒体自噬相关的靶点。
- 防己黄芪汤、木防己汤、芪玉三龙汤、扶正抗癌汤等复方在中国临床应用千年,临床疗效可观,但其成分复杂,需分离活性成分以阐明机制。
关键数值与推荐
- 天然草本植物及其活性成分肝腎毒性较常规西药低,安全性较好。
- 中药复方、单味药提取物及活性成分具有抗肿瘤、抗炎、抗菌、抗氧化等多种生物活性。
临床怎么用
- 临床可关注防己黄芪汤、木防己汤、芪玉三龙汤、扶正抗癌汤等复方在NSCLC中的潜在应用,但需结合体外机制、体内药理和临床疗效评估。
- 使用中药复方或活性成分时,应重视植物资源评估、质量控制及毒理学研究,确保数据适合进一步审查。
局限性
- 许多复方成分复杂、加工精细,其活性成分的分子机制尚需通过细胞和动物研究进一步阐明。
- 需开展体外机制研究、体内药理评价和临床疗效评估,并全面评估植物资源、质量控制及毒理学,以保障数据适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Chinese herbal medicine constitutes a substantial cultural and scientific resource for the Chinese nation, attracting considerable scholarly interest due to its intrinsic characteristics of "multi-component, multi-target, and multi-pathway" interactions. Simultaneously, it aligns accurately with the intricate and continuously evolving progression of non-small cell lung cancer (NSCLC). Furthermore, contemporary pharmacological studies indicate that natural herbaceous plants and their bioactive compounds exhibit a diverse array of biological activities, including antioxidant, anti-inflammatory, and anti-tumor effects, among others. Additionally, these substances have been demonstrated to possess a degree of safety, particularly in terms of exhibiting comparatively lower levels of toxicity to the liver and kidneys when contrasted with conventional Western medicine. Thus, the development of herbal plants, which includes both single herbs and composite formulations, as well as their bioactive constituents, through the targeted regulation of ferroptosis and mitophagy, presents substantial potential and instills considerable hope for individuals diagnosed with NSCLC. AIM OF THE REVIEW: This review aims to conduct a critical analysis of the ethnopharmacological applications of natural herbaceous plants in relation to ferroptosis and mitophagy in NSCLC. The objective is to evaluate the potential advantages of prioritizing specific phytochemical constituents found in these plants, which may serve as novel therapeutic candidates informed by ethnobotanical knowledge. Additionally, this study seeks to enhance the current pharmacological applications of natural herbaceous plants. METHODS: An investigation into natural herbal remedies for NSCLC was conducted, with a particular emphasis on the ferroptosis and mitophagy pathways. This study utilized traditional medical texts and ethnomedicinal literature as primary sources. Furthermore, relevant information related to ethnobotany, phytochemistry, and pharmacology is obtained from online databases, including PubMed and the China National Knowledge Infrastructure (CNKI), among others. "Traditional Chinese medicine compound preparations", "single herb extracts", "active compounds", "NSCLC", "ferroptosis", and "mitophagy" were used as keywords when searching the databases. Consequently, pertinent articles published in recent years were collected and analyzed. RESULTS: Given the complex etiology of NSCLC, treatment strategies that concentrate exclusively on ferroptosis or mitophagy often demonstrate limitations. In this regard, the utilization of herbal plants offers unique benefits in the management of NSCLC. The rationale can be summarized within the following two dimensions: Firstly, due to the molecular mechanisms of ferroptosis and mitophagy involving multiple signaling pathways (including PINK1/Parkin, HMGB1, system Xc-/GPX4/GSH, FSP1/CoQ10/NAD (P) H, and so on), sometimes drugs with a single target are difficult to involve multiple pathways. Fortunately, there is an expanding body of evidence suggesting that various herbaceous plants and their bioactive compounds can affect multiple biological targets. Moreover, these compounds seem to interact with several targets associated with ferroptosis and mitophagy in NSCLC (such as NIX, BNIP3, FUNDC1, GPX4, FSP1, P53, Nrf2, LncRNA, and so on). Secondly, Herbaceous plants and their bioactive compounds have been shown to possess a favorable safety profile, particularly with respect to reduced hepatotoxicity and nephrotoxicity in comparison to conventional Western medicine. For example, Numerous compound formulations, such as Fangji Huangqi decoction, Mufangji decoction, Qiyu Sanlong decoction, and Fuzheng Kangai decoction, have been employed in China for millennia, and their clinical efficacy appears to be quite promising. Notably, In recent years, numerous researchers have sought to isolate active constituents from clinically effective compound formulations through the application of chemical methodologies. This endeavor has been driven by the necessity to tackle challenges related to complex ingredient compositions and sophisticated processing. These active compounds have been employed in cellular and animal studies to elucidate the molecular mechanisms underlying these formulations. CONCLUSIONS: The Asian region has a long-standing historical tradition of employing natural herbaceous plants for traditional medicinal purposes. Phytochemical and pharmacological studies have shown that various compound preparations derived from traditional Chinese medicine, along with individual herb extracts and their active constituents, display a range of bioactive effects. These effects encompass anti-tumor, anti-inflammatory, antibacterial, and antioxidant properties, among others. Numerous traditional compound formulations originating from China have emerged as promising candidates for the development of pharmacological agents targeting NSCLC. It is noteworthy that a variety of compound formulations aimed at the ferroptosis and mitophagy pathways, which demonstrate unique therapeutic effects on NSCLC, are presently under extensive investigation by an increasing number of researchers. Therefore, it is imperative to consider in vitro mechanistic studies, in vivo pharmacological evaluations, and assessments of clinical efficacy. Furthermore, it is essential to conduct a comprehensive assessment of plant resources, implement quality control measures, and engage in toxicological research to ensure that the data is appropriate for further examination.
引用
- Yang Y, Jiang B, Shi L, et al. The potential of natural herbal plants in the treatment and prevention of non-small cell lung cancer: An encounter between ferroptosis and mitophagy. J Ethnopharmacol. 2025. PMID: 40015539. doi:10.1016/j.jep.2025.119555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。